Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP969962.RA2uHuol2_LI26_9rYJZgMhmFrE0ncp1WOXfovdDglsYs130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP969962.RA2uHuol2_LI26_9rYJZgMhmFrE0ncp1WOXfovdDglsYs130_assertion type Assertion NP969962.RA2uHuol2_LI26_9rYJZgMhmFrE0ncp1WOXfovdDglsYs130_head.
- NP969962.RA2uHuol2_LI26_9rYJZgMhmFrE0ncp1WOXfovdDglsYs130_assertion description "[We suggest that DNA methylation of H19 and PEG1 differentially methylated regions (DMRs) may provide novel biomarkers useful for screening, diagnosis and, potentially, for improving the clinical management of women with human ovarian cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP969962.RA2uHuol2_LI26_9rYJZgMhmFrE0ncp1WOXfovdDglsYs130_provenance.
- NP969962.RA2uHuol2_LI26_9rYJZgMhmFrE0ncp1WOXfovdDglsYs130_assertion evidence source_evidence_literature NP969962.RA2uHuol2_LI26_9rYJZgMhmFrE0ncp1WOXfovdDglsYs130_provenance.
- NP969962.RA2uHuol2_LI26_9rYJZgMhmFrE0ncp1WOXfovdDglsYs130_assertion SIO_000772 22443985 NP969962.RA2uHuol2_LI26_9rYJZgMhmFrE0ncp1WOXfovdDglsYs130_provenance.
- NP969962.RA2uHuol2_LI26_9rYJZgMhmFrE0ncp1WOXfovdDglsYs130_assertion wasDerivedFrom befree-2016 NP969962.RA2uHuol2_LI26_9rYJZgMhmFrE0ncp1WOXfovdDglsYs130_provenance.
- NP969962.RA2uHuol2_LI26_9rYJZgMhmFrE0ncp1WOXfovdDglsYs130_assertion wasGeneratedBy ECO_0000203 NP969962.RA2uHuol2_LI26_9rYJZgMhmFrE0ncp1WOXfovdDglsYs130_provenance.